Publications by authors named "N Velez de Mendizabal"
DZIF-10c (BI 767551) is a recombinant human monoclonal antibody of the IgG1 kappa isotype. It acts as a SARS-CoV-2 neutralizing antibody. DZIF-10c has been developed for both systemic exposure by intravenous infusion as well as for specific exposure to the respiratory tract by application as an inhaled aerosol generated by a nebulizer.
View Article and Find Full Text PDFArticle Synopsis
- Chronic illnesses significantly impact healthcare globally, making it essential to explore effective physical activity programs to enhance patients' health and quality of life.
- The EfiKroniK study aims to assess the effectiveness of a tailored physical exercise program for patients with chronic conditions such as cancer, COPD, and schizophrenia, comparing outcomes like cardiorespiratory capacity and quality of life between two groups.
- This multicentre clinical trial will evaluate not only physical health outcomes but also psychological and social factors, incorporating patient feedback to refine the program and identify challenges in its implementation over a 1-year follow-up period.
Background: Colorectal cancer (CRC) is a major public health problem due to its incidence and mortality. Screening programmes help decrease its impact on the population through early detection. However, the uneven distribution of social determinants of health can cause inequalities.
View Article and Find Full Text PDFBackground: While it is known that a variety of factors (biological, behavioural and interventional) play a major role in the health of individuals and populations, the importance of the role of social determinants is less clear. The effect of social inequality on population-based screening for colorectal cancer (CRC) could limit the value of such programmes. The present study aims to determine whether such inequalities exist.
View Article and Find Full Text PDF